Off label use of ivermectin?

In short: off-label use means using ivermectin for conditions or in doses that aren’t specifically approved by regulators. Clinicians do use it off-label for a variety of parasitic infections, but the evidence and safety profile can vary a lot by indication, and dosing often differs from the approved uses. Here are some of the more common off-label or non–FDA-approved-in-all-settings uses you might see in practice:

- Scabies (uncomplicated): Very common off-label use. Often given as oral ivermectin (about 200 mcg/kg, sometimes repeated after 1–2 weeks) either alone or with topical treatments. Crusted (Norwegian) scabies is more complex and may require higher or multiple doses plus intensive topical therapy.

- Pediculosis (lice): Used as an alternative when topical treatments fail or in outbreaks/outdoor settings. Dosing is typically similar to standard regimens, but evidence is mixed and practice varies by region.

- Strongyloidiasis in certain settings: In many places, oral ivermectin is a preferred option for Strongyloides infection, especially when other agents aren’t available or when rapid parasite clearance is needed. In some regulatory contexts this may be considered off-label if the official labeling doesn’t list that specific use.

- Other parasitic infections with limited data: Some case reports or small studies describe use for infections such as cutaneous larva migrans, gnathostomiasis, capillariasis, and certain nematode infections. These are not supported by large trials and are far less standardized.

- Myiasis (parasitic skin/soft-tissue infection): There are case reports of using ivermectin as part of treatment, particularly when mechanical removal is inadequate or impractical.

What about rosacea? Topical ivermectin 1% is an approved indication for rosacea; that’s not off-label, it’s an approved use.

Important safety notes
- Dosing and duration vary by indication and patient factors. Do not self-treat; off-label uses should be guided by a clinician.
- Potential adverse effects include dizziness, fatigue, rash, or GI symptoms. Higher or repeated doses can increase the risk of neurotoxicity, especially if there is a heavy parasite load or certain coexisting conditions.
- Special considerations: risk of severe reactions if used in people with high Loa loa microfilarial loads; pregnancy and breastfeeding considerations; drug interactions; and contraindications in certain pediatric or weight-based scenarios. Always refer to local guidelines and drug labels.
- Not a proven treatment for conditions like COVID-19 outside of well-controlled trials.

If you’re considering ivermectin for a specific condition, tell me:
- the exact condition (diagnosis or symptoms),
- your country or region (to reflect local approvals/guidelines),
- the patient’s age/weight (and pregnancy status if relevant),
- any other medicines or medical conditions.

With that, I can summarize the current guidelines and evidence for that particular off-label use and help you weigh risks and alternatives.